Patents Assigned to AvantiCell Science Ltd
  • Compositions and methods for the control of mammary cell number
    Patent number: 7932229
    Abstract: The present invention provides new methods and uses of peptides in effecting a reduction in mammary cell number. The discovery that these peptides reduce mammary cell number further enables the use of these peptides in the treatment of cancer where the peptides can be used to reduce cell number and accordingly reduce or prevent tumour development. The inventor has further shown that the peptides have specific utility in the treatment of breast cancer.
    Type: Grant
    Filed: October 21, 2005
    Date of Patent: April 26, 2011
    Assignee: AvantiCell Science Ltd
    Inventor: Colin James Wilde